+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Selective Serotonin Reuptake Inhibitor"

From
From
From
Antidepressants - Global Strategic Business Report - Product Thumbnail Image

Antidepressants - Global Strategic Business Report

  • Report
  • April 2025
  • 174 Pages
  • Global
From
From
Fluoxetine Market Report 2025 - Product Thumbnail Image

Fluoxetine Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Major Depressive Disorder Market Report 2025 - Product Thumbnail Image

Major Depressive Disorder Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Postpartum Depression Market Report 2025 - Product Thumbnail Image

Postpartum Depression Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antidepressants Market Report 2025 - Product Thumbnail Image

Antidepressants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bipolar Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Anxiety Disorder Treatment - Global Strategic Business Report - Product Thumbnail Image

Anxiety Disorder Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
From
Depression Drugs Market 2025-2033 - Product Thumbnail Image

Depression Drugs Market 2025-2033

  • Report
  • March 2025
  • 148 Pages
  • Global
From
From
From
Loading Indicator

Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of drugs used to treat mental disorders such as depression, anxiety, and obsessive-compulsive disorder. SSRIs work by increasing the amount of serotonin, a neurotransmitter, in the brain. This helps to improve mood and reduce symptoms of mental illness. SSRIs are generally considered to be safer and more effective than other types of antidepressants, and they are often prescribed as a first-line treatment for mental disorders. The SSRI market is highly competitive, with many pharmaceutical companies offering different brands of SSRIs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. These companies have developed a wide range of SSRIs, including Prozac, Zoloft, Paxil, and Lexapro. Other companies, such as Mylan and Teva, also offer generic versions of SSRIs. Show Less Read more